CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
Ryuma Tokunaga, Wu Zhang, Madiha Naseem, Alberto Puccini, Martin D. Berger, Shivani Soni, Michelle McSkane, Hideo Baba, Heinz‐Josef Lenz
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.ctrv.2017.11.007
- Published
- Nov 26, 2017
- Venue
- Cancer Treatment Reviews
- DOI
- 10.1016/j.ctrv.2017.11.007
- PubMed
- 29207310
- Categories
- Chemokine receptors and signaling
- Provenance
- openalex